| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $36.8M | — | — |
| R&D Expense | $9.0M | — | +217.2% |
| SG&A Expense | $4.6M | — | +25.2% |
| Operating Income | $23.3M | — | +457.7% |
| Pre-tax Income | $24.1M | — | +488.2% |
| Income Tax | $0 | — | — |
| Net Income | $24.1M | — | +574.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $98.1M | +10.3% | +215.8% |
| Current Assets | $98.8M | +9.9% | +209.6% |
| Total Assets | $98.8M | +9.9% | +208.5% |
| Current Liabilities | $6.9M | +3.6% | +59.4% |
| Total Liabilities | $8.9M | -65.2% | -61.7% |
| Stockholders' Equity | $90.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $9.2M | — | +261.0% |
| +1035.8% |